Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept Treat and Extend Regimen for Diabetic Macular Edema (TADI)
NCT02633852Phase 4Completed
- Sponsor
- Hadassah Medical Organization
- Start
- May 2016
- Primary completion
- Aug 2018
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
01
Overview
A Phase 4 trial of aflibercept in diabetic macular edema (DME), sponsored by Hadassah Medical Organization. Started May 2016; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02633852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633852.